If You Invested $100 In Cytokinetics Stock 10 Years Ago, You Would Have This Much Today
Cytokinetics (NASDAQ:CYTK) has outperformed the market over the past 10 years by 7.78% on an annualized basis producing an average annual return of 21.28%. Currently, Cytokinetics has a market capitalization of $10.34
Cytokinetics stock grew much faster than most companies over the last 10 years, earning about 21% per year. When you look at a company's past performance, remember that strong growth in the past doesn't promise what will happen next.
Last session drawn · prints held ~15 minutes · licensed exchange data
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only — not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.